Lumida
/TXMD
⌘K
TherapeuticsMD Inc

TherapeuticsMD Inc

TXMD
$2.16USD+2.86%+0.06 today

MARKET CAP

25.0M

P/E (TTM)

108.0x

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$1
$3
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$2.6M$70.0M$1.3M$1.8M$3.0M
YoY %-96.0%+2619.1%-98.1%+35.3%+71.6%
P / Sales55.0x0.8x18.7x5.6x6.2x
EV / Sales132.0x1.1x26.1x9.3x7.3x
Gross Profit, Adj.$1.2M$68.6M$1.3M$1.8M$3.0M
YoY %-97.6%+5755.3%-98.1%+35.3%+71.6%
Margin %45.5%98.0%100.0%100.0%100.0%
EV / Gross Profit290.1x1.1x26.1x9.3x7.3x
EBITDA, Adj.$-78.8M$11.9M$-7.6M$-5.6M$-4.0M
YoY %+48.0%+115.0%-164.1%+26.3%+28.5%
Margin %-3064.2%16.9%-583.8%-318.2%-132.6%
EV / EBITDA-4.3x6.4x-4.5x-2.9x-5.5x
EBIT$-79.6M$1.2M$-8.5M$-6.1M$-4.4M
YoY %+48.8%+101.5%-815.6%+28.3%+28.2%
Margin %-3092.8%1.7%-654.6%-347.1%-145.3%
EV / EBIT-4.3x63.6x-4.0x-2.7x-5.0x
Net Income$-172.4M$112.0M$-10.3M$-2.2M$-569,000
YoY %+6.1%+165.0%-109.2%+78.8%+73.9%
Net Margin-6700.9%160.1%-789.4%-123.9%-18.8%
EPS (GAAP)-$21.66$11.96-$0.99-$0.19-$0.05
YoY %+35.3%+155.2%-108.3%+80.8%+73.7%